Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 26.30
+2.12 (8.77%)
At close: Feb 13, 2026
Medtide Market Cap
Medtide has a market cap or net worth of 3.43 billion as of February 13, 2026.
Market Cap
3.43B
Enterprise Value
2.23B
Revenue
546.29M
Ranking
n/a
PE Ratio
24.94
Stock Price
26.30
Market Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.43B, a decrease of -21.49%. That is a compound annual growth rate of -32.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.43B | -20.67% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laekna | 5.26B |
| Viva Biotech Holdings | 5.06B |
| Shandong Boan Biotechnology | 4.85B |
| TYK Medicines | 4.85B |
| Jacobio Pharmaceuticals Group | 4.78B |
| Qyuns Therapeutics | 4.73B |
| Beijing Luzhu Biotechnology | 4.04B |
| AIM Vaccine | 3.97B |